Comment on: Pantalone et al. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis. Diabetes Care 2010;33:1224-1229.

Autor: Khalangot MD, Khalangot, Mykola D

Publikováno v: Diabetes Care; Aug2011, Vol. 34 Issue 8, pe138-e138, 1p

Neuronal Dysfunction Is Linked to the Famine-Associated Risk of Proliferative Retinopathy in Patients With Type 2 Diabetes.

Autor: Fedotkina O; Department of Clinical Science, Center for Diabetes Research, University of Bergen, Bergen, Norway., Jain R; Department of Clinical Sciences, Lund University Diabetes Center, Skane University Hospital, Malmö, Sweden., Prasad RB; Department of Clinical Sciences, Lund University Diabetes Center, Skane University Hospital, Malmö, Sweden., Luk A; Prince of Wales Hospital, Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., García-Ramírez M; Vall d'Hebron Research Institute and CIBERDEM, Barcelona, Spain., Özgümüs T; Department of Clinical Science, Center for Diabetes Research, University of Bergen, Bergen, Norway., Cherviakova L; Chernihiv Regional Hospital, Chernihiv, Ukraine., Khalimon N; City Hospital No. 2, Chernihiv, Ukraine., Svietleisha T; City Hospital No. 1, Chernihiv, Ukraine., Buldenko T; Department of Health Care of Chernihiv Regional State Administration, Chernihiv, Ukraine., Kravchenko V; Komisarenko Institute of Endocrinology and Metabolism, Kyiv, Ukraine., Jain D; Department of Clinical Sciences, Lund University Diabetes Center, Skane University Hospital, Malmö, Sweden., Vaag A; Steno Diabetes Center Copenhagen, Copenhagen, Denmark., Chan J; Prince of Wales Hospital, Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Khalangot MD; Komisarenko Institute of Endocrinology and Metabolism, Kyiv, Ukraine.; Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine., Hernández C; Vall d'Hebron Research Institute and CIBERDEM, Barcelona, Spain., Nilsson PM; Department of Clinical Sciences, Lund University Diabetes Center, Skane University Hospital, Malmö, Sweden., Simo R; Vall d'Hebron Research Institute and CIBERDEM, Barcelona, Spain., Artner I; Department of Clinical Sciences, Lund University Diabetes Center, Skane University Hospital, Malmö, Sweden., Lyssenko V; Department of Clinical Science, Center for Diabetes Research, University of Bergen, Bergen, Norway.; Department of Clinical Sciences, Lund University Diabetes Center, Skane University Hospital, Malmö, Sweden.

Publikováno v: Frontiers in neuroscience [Front Neurosci] 2022 May 05; Vol. 16, pp. 858049. Date of Electronic Publication: 2022 May 05 (Print Publication: 2022).

Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings.

Autor: Magliano DJ; Department of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. Electronic address: dianna.magliano@baker.edu.au., Chen L; Department of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Islam RM; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Carstensen B; Clinical Epidemiology, Steno Diabetes Center Copenhagen, Gentofte, Denmark., Gregg EW; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK., Pavkov ME; Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA., Andes LJ; Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA., Balicer R; Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel., Baviera M; Laboratory of Cardiovascular Prevention, Mario Negri Institute for Pharmacological Research IRCCS, Milan, Italy., Boersma-van Dam E; Department of General Practice, Netherlands Institute for Health Services Research, Utrecht, Netherlands., Booth GL; Department of Medicine, University of Toronto, Toronto, ON, Canada., Chan JCN; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China., Chua YX; Epidemiology and Disease Control Division, Public Health Group, Ministry of Health, Singapore., Fosse-Edorh S; Department of Non-Communicable Diseases and Trauma, Santé Publique France, Saint-Maurice, France., Fuentes S; Department of Non-Communicable Diseases and Trauma, Santé Publique France, Saint-Maurice, France., Gulseth HL; Department for Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway., Gurevicius R; Center of Health Information, Institute of Hygiene, Vilnius, Lithuania; Faculty of Public Governance and Business, Mykolas Romeris University, Vilnius, Lithuania., Ha KH; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea., Hird TR; Department of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Jermendy G; 3rd Medical Department, Bajcsy-Zsilinszky Hospital, Budapest, Hungary., Khalangot MD; Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences, Kyiv, Ukraine; Endocrinology Department, Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine., Kim DJ; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea., Kiss Z; 2nd Department of Medicine and Nephrological Center, Medical Faculty, University of Pécs, Pécs, Hungary., Kravchenko VI; Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences, Kyiv, Ukraine., Leventer-Roberts M; Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel; Department of Pediatrics and Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lin CY; General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan., Luk AOY; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China., Mata-Cases M; CIBER of Diabetes and Associated Metabolic Diseases, Instituto de Salud Carlos III, Barcelona, Spain; DAP-Cat Group, Institut Català de la Salut, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Barcelona, Spain., Mauricio D; CIBER of Diabetes and Associated Metabolic Diseases, Instituto de Salud Carlos III, Barcelona, Spain; DAP-Cat Group, Institut Català de la Salut, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Barcelona, Spain; Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain., Nichols GA; Science Programs Department, Kaiser Permanente Center for Health Research, Portland, OR, USA., Nielen MM; Department of General Practice, Netherlands Institute for Health Services Research, Utrecht, Netherlands., Pang D; Epidemiology and Disease Control Division, Public Health Group, Ministry of Health, Singapore., Paul SK; Melbourne EpiCentre, University of Melbourne, Melbourne, VIC, Australia., Pelletier C; Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, ON, Canada., Pildava S; Research and Health Statistics Department, Centre for Disease Prevention and Control, Riga, Latvia., Porath A; Research Institute, Maccabi Healthcare Services, Tel Aviv, Israel; Faculty of Health, Ben Gurion University, Beer-Sheva, Israel., Read SH; Usher Institute, University of Edinburgh, Edinburgh, UK., Roncaglioni MC; Laboratory of Cardiovascular Prevention, Mario Negri Institute for Pharmacological Research IRCCS, Milan, Italy., Lopez-Doriga Ruiz P; Department for Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway., Shestakova M; Diabetes Institute, Endocrinology Research Center, Moscow, Russia., Vikulova O; Diabetes Institute, Endocrinology Research Center, Moscow, Russia., Wang KL; General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan., Wild SH; Usher Institute, University of Edinburgh, Edinburgh, UK., Yekutiel N; Research Institute, Maccabi Healthcare Services, Tel Aviv, Israel., Shaw JE; Department of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; School of Life Sciences, Latrobe University, Bundoora, VIC, Australia.

Publikováno v: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2021 Apr; Vol. 9 (4), pp. 203-211. Date of Electronic Publication: 2021 Feb 23.

Additional Impact of Glucose Tolerance on Telomere Length in Persons With and Without Metabolic Syndrome in the Elderly Ukraine Population.

Autor: Khalangot MD; Epidemiology Department, Komisarenko Institute of Endocrinology and Metabolism, Kyiv, Ukraine.; Endocrinology Department, Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine., Krasnienkov DS; Laboratory of Epigenetics, Chebotariov Institute of Gerontology, Kyiv, Ukraine., Chizhova VP; Laboratory of Epigenetics, Chebotariov Institute of Gerontology, Kyiv, Ukraine., Korkushko OV; Laboratory of Epigenetics, Chebotariov Institute of Gerontology, Kyiv, Ukraine., Shatilo VB; Laboratory of Epigenetics, Chebotariov Institute of Gerontology, Kyiv, Ukraine., Kukharsky VM; Laboratory of Epigenetics, Chebotariov Institute of Gerontology, Kyiv, Ukraine., Kravchenko VI; Epidemiology Department, Komisarenko Institute of Endocrinology and Metabolism, Kyiv, Ukraine., Kovtun VA; Epidemiology Department, Komisarenko Institute of Endocrinology and Metabolism, Kyiv, Ukraine., Guryanov VG; Public Health Management Department, Bogomolets National Medical University, Kyiv, Ukraine., Vaiserman AM; Laboratory of Epigenetics, Chebotariov Institute of Gerontology, Kyiv, Ukraine.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2019 Feb 28; Vol. 10, pp. 128. Date of Electronic Publication: 2019 Feb 28 (Print Publication: 2019).

Glucose Tolerance Testing and Anthropometric Comparisons Among Rural Residents of Kyiv Region: Investigating the Possible Effect of Childhood Starvation-A Community-Based Study.

Autor: Khalangot MD; Endocrinology Department, Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine.; Epidemiology Department, Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine., Kovtun VA; Epidemiology Department, Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine., Okhrimenko NV; Epidemiology Department, Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine., Gurianov VG; Medical & Biological Physics and Informatics Department, Bogomolets National Medical University, Kyiv, Ukraine., Kravchenko VI; Epidemiology Department, Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.

Publikováno v: Nutrition and metabolic insights [Nutr Metab Insights] 2017 Nov 27; Vol. 10, pp. 1178638817741281. Date of Electronic Publication: 2017 Nov 27 (Print Publication: 2017).